Amalgamated Bank’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Amalgamated Bank’s Portfolio THRN Stock Details THRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,494	Closed	-$15K	–	3027
2023 Q3	$15K	Hold	1,494	–	–	﹤0.01%	2799
2023 Q2	$7K	Sell	1,494 -148	-9%	-$680	﹤0.01%	2988
2023 Q1	$8K	Sell	1,642 -269	-14%	-$1.18K	﹤0.01%	2853
2022 Q4	$7K	Hold	1,911	–	–	﹤0.01%	2916
2022 Q3	$9K	Buy	1,911 +33	+2%	+$166	﹤0.01%	2958
2022 Q2	$9K	Buy	1,878 +851	+83%	+$5.17K	﹤0.01%	3009
2022 Q1	$7K	Buy	+1,027	New	+$5.53K	﹤0.01%	3008

Amalgamated Bank's THRN Position: Q4 2023 in Review

Amalgamated Bank sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 1,494 shares — an estimated $15K sold.

Amalgamated Bank first reported a position in THRN in Q1 2022 and held it in 7 quarters. The position peaked at $15K in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

Amalgamated Bank reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Amalgamated Bank sold 1,494 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $15K.
Amalgamated Bank first reported a position in Thorne Healthtech, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
Amalgamated Bank's Thorne Healthtech, Inc. Common Stock position peaked at $15K in Q3 2023.
0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Amalgamated Bank's 13F filing for Q4 2023, filed 6 Feb 2024.